Dr. Ralph Dittman, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 39375 Amethyst St, Steamboat Springs, CO 80487 Phone: 970-871-0305 |
News Archive
Researchers are making great strides in understanding the development and treatment of inflammatory bowel disease, a chronic inflammatory condition of the digestive tract that affects more than a half million Americans, according to several studies being presented at Digestive Disease Week® 2009 (DDW®). DDW is the largest international gathering of physicians and researchers in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
The concentration of acetate increases particularly sharply at the site of an infection in the body. As reported in the journal Cell Metabolism by a team of researchers from the University of Basel and colleagues, acetate supports the function of certain immune cells and thus helps to eliminate pathogens safely and efficiently.
The Asbestos Disease Awareness Organization (ADAO) today reaffirmed the need for an asbestos ban this Labor Day, as America honors the workforce that continues to power the nation, even in the wake of the economic downturn.
Solvay Pharmaceuticals, Inc. has submitted a New Drug Application (NDA) for cilansetron, an investigational product being studied for the treatment of irritable bowel syndrome with diarrhea predominance (IBS-D), to the FDA on June 30, 2004.
Delegates and officials from Bangladesh, Bhutan, Nepal, Pakistan, Sri Lanka, Maldives, and Thailand representing their health and medical research councils on Tuesday in New Delhi concluded a three-day South Asian Forum for Health Research (SAHFer) hosted by the Indian Council of Medical Research (ICMR), Pharmabiz.com reports.
› Verified 5 days ago